ASX Announcements
| 2012 — Quarter 1 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Change in substantial holding | 26/03/2012 | ||
| ACR | Acrux announces board changes | 22/02/2012 | ||
| ACR | Acrux reports half-year profit of $5.1 million | 22/02/2012 | ||
| ACR | Investor presentation, 22 February 2012 | 22/02/2012 | ||
| ACR | Half Yearly Report and Accounts | 22/02/2012 | ||
| ACR | Notice of Allowance in USA for Axiron applicator patent | 31/01/2012 | ||
| ACR | Marketing approval granted for Ellavie in Switzerland | 30/01/2012 | ||
| ACR | Lilly comments on Axiron at JP Morgan Healthcare Conference | 13/01/2012 |
| 2012 — Quarter 2 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Recuvyra approved by FDA | 26/06/2012 | ||
| ACR | Patent application update | 21/06/2012 | ||
| ACR | Axiron Marketing Authorisation Granted in Australia | 25/05/2012 | ||
| ACR | Becoming a substantial holder | 23/05/2012 | ||
| ACR | Change in substantial holding from AMP | 15/05/2012 | ||
| ACR | Change in substantial holding | 14/05/2012 | ||
| ACR | Change in substantial holding | 10/05/2012 | ||
| ACR | Change in substantial holding from AMP | 10/05/2012 | ||
| ACR | Becoming a substantial holder from AMP | 08/05/2012 | ||
| ACR | Change in substantial holding | 07/05/2012 | ||
| ACR | Becoming a substantial holder | 07/05/2012 | ||
| ACR | Investor presentation, 7 May 2012 | 07/05/2012 | ||
| ACR | Change in substantial holding | 02/05/2012 | ||
| ACR | Acrux announces further board change | 01/05/2012 | ||
| ACR | Initial Director`s Interest Notice | 01/05/2012 | ||
| ACR | Final Director`s Interest Notice | 01/05/2012 | ||
| ACR | Change of Director`s Interest Notice | 01/05/2012 | ||
| ACR | Change in substantial holding | 26/04/2012 | ||
| ACR | Axiron market update | 26/04/2012 | ||
| ACR | Axiron marketing authorisation granted in Canada | 12/04/2012 |
| 2012 — Quarter 3 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Becoming a substantial holder | 17/09/2012 | ||
| ACR | Ceasing to be a substantial holder from AMP | 13/09/2012 | ||
| ACR | Change of Director's Interest Notice | 13/09/2012 | ||
| ACR | Change in substantial holding from AMP | 07/09/2012 | ||
| ACR | Ceasing to be a substantial holder | 29/08/2012 | ||
| ACR | Dividend, June 2012 results and Axiron update | 23/08/2012 | ||
| ACR | Investor presentation, 23 August 2012 | 23/08/2012 | ||
| ACR | Appendix 4E and Financial Report for 30 June 2012 | 23/08/2012 | ||
| ACR | Change in substantial holding from AMP | 17/08/2012 | ||
| ACR | Change in substantial holding | 08/08/2012 | ||
| ACR | Final Director's Interest Notice | 02/07/2012 |
| 2012 — Quarter 4 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Ceasing to be a substantial holder | 20/12/2012 | ||
| ACR | Becoming a substantial holder | 19/12/2012 | ||
| ACR | Becoming a substantial holder | 18/12/2012 | ||
| ACR | Change of Director's Interest Notice | 27/11/2012 | ||
| ACR | 2012 AGM Results of Meeting | 22/11/2012 | ||
| ACR | 2012 AGM Presentation | 22/11/2012 | ||
| ACR | 2012 AGM Chairman's Address | 22/11/2012 | ||
| ACR | 2012 Annual Report | 19/10/2012 | ||
| ACR | Notice of Annual General Meeting/Proxy Form | 19/10/2012 | ||
| ACR | Change in substantial holding | 12/10/2012 | ||
| ACR | Change of Director's Interest Notice | 02/10/2012 |